Genomma Lab Internacional

Historical price data

Genomma Lab Internacional's mission is to improve health and well-being through innovative, safe, and effective products, while generating value for stakeholders. The company has achieved a commanding market position across 18 countries in the Americas, supported by a portfolio of over 30 iconic brands like Tío Nacho and Cicatricure. Its strategy focuses on brand equity, marketing excellence, and an extensive distribution network to capitalize on the growing consumer healthcare segment in emerging markets. With a market valuation of $16.65B, it stands as a financially robust leader in the Latin American OTC and personal care landscape.

An integrated brand development, manufacturing, and commercialization platform focused on OTC pharmaceuticals, generics, and personal care products, leveraging deep consumer insights, pan-regional distribution, and marketing excellence.

Genomma Lab competes with global OTC divisions (e.g., Kenvue, Bayer), large Latin American pharma conglomerates (e.g., Hypera, Bagó), and multinational consumer goods companies. Its advantages are deep local brand relevance, an integrated cost structure, and an unrivalled distribution network across the region.